Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) had caused catastrophic losses in swine industry in China. The current inactivated vaccine provided only limited protection, and the attenuated live vaccine could protect piglets against the HP-PRRSV but there was a possibility that the attenuated virus returned to high virulence. In this study, the eukaryotic expression vector pVAX1 ß was modified under the control of rabbit b-globin intron II gene and the modified vector pMVAX1 ß was constructed. Porcine interleukin-2 (IL-2) and GP3-GP5 fusion protein of HP-PRRSV strain SD-JN were highly expressed by pMVAX1 
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) is a small, enveloped single-stranded, positive-sense RNA virus. It is a member of the genus Arterivirus, family Arteriviridae, order Nidovirales [1, 2] . The length of PRRSV genome is approximately 15 kb, and the genome codes for two large non-structural polyproteins (PP1a and PP1a/1b) in the 59-terminal 12 kb region, and 8 structural proteins in the 39-terminal 3 kb region: GP2 (glycoprotein 2), E (small envelope), GP3, GP4, GP5, GP5a, M (membrane), and N (nucleocapsid) proteins in order [3] [4] [5] . It was reported that immunization of GP3 and GP5 fusion protein has been shown to elicit enhanced immune responses [6] and GP3-GP5 has been selected as the candidate antigen of porcine reproductive and respiratory syndrome (PRRS) genetic engineering vaccines [7] [8] [9] [10] .
PRRS is one of the most economically significant viral diseases of swine, frustrating challenge to the global swine industry [11, 12] . In China, highly pathogenic PRRSV has been isolated and identified, causing a large-scale outbreak of PRRSV since 2006 [13] [14] [15] [16] . Killed-PRRSV vaccines are less effective in prevention of infection [9] . Attenuated live vaccine could protect piglets from lethal challenge but there is a possibility that the attenuated virus returned to high virulence [17] . Thus, PRRS genetic engineering vaccines have been developed to control this disease [7, 18, 19] . However, we usually meet the cases that the DNA or recombinant protein cannot effectively induce immune response. An alternative approach is the co-delivery of cytokines to up-regulate the immune response [8, 9, 20] , another one is using gene regulatory elements to improve the expression level of the protein antigen [21, 22] .
IL-2 is an essential cytokine secreted mainly by activated T lymphocytes and plays a pivotal role in the replication and differentiation of T and B lymphocytes, monocytes, and natural killer cells [23] . IL-2 is one of cytokine adjuvants and enhances the protection against challenge with the infectious agent, including PRRSV [24] [25] [26] . However, the immune enhancing effects could not provide complete protection against PRRSV challenge [25, 26] . It might be related to the low expression level of IL-2 or using N protein of PRRSV as the antigen.
b-Globin Intron II gene was one of gene regulatory elements and used in expression systems to enhance the expression level of target proteins [21, 22] . It was found that addition of the rabbit bGlobin Intron II gene in DNA vaccine expressing the respiratory syncytial virus (RSV) fusion (F) protein (DNA-F) resulted in an increase of protein expression in vitro and critically contributed to the protection against respiratory syncytial virus infection in vivo [22] . The protein level expressed by commercially available pVAX1 ß vector (Invitrogen, Carlsbad, CA, USA) was low. Whether insertion of the rabbit b-Globin Intron II gene to pVAX1 ß vector could increase the protein expression level was never reported.
In this study, we first used the rabbit b-Globin Intron II gene as gene regulatory element to engineer the eukaryotic expression vector pVAX1 ß and constructed the gene regulatory plasmid pMVAX1
Materials and Methods

Ethics Statement
The animal experiments were approved by Jiangsu Provincial Science and Technology department in China and conducted accordingly. Experiments conformed to the local (Regulations for the administration of affairs concerning experimental animals) and international (Dolan K. 2007 Second Edition of Laboratory Animal Law. Blackwell, UK) guidelines on the ethical use of animals.
Viruses and cells
HP-PRRSV strain SD-JN was kept in our laboratory [27] . MARC-145 cells were used to propagate and titrate HP-PRRSV SD-JN strain. The infected cell lysates were clarified, titrated, diluted to 1610 5 TCID 50 /ml and stored at 220uC to be used for animal challenge. The sixth passage (F6) MARC-145 cell culture supernatant was filtrated through a 0.45 mm filter and SD-JN PRRSV was concentrated from the supernatant by ultracentrifugation at 120,0006g (SW 40 rotor, Beckman) at 4uC for 2 h. The virus pellet was collected, diluted with TNE buffer [50 mM TrisHCl (pH 7.5), 100 mM NaCl, 1 mM EDTA] and then layered on the top of 25-65% (w/v) sucrose gradients and at the same time centrifuged at 120,0006g (SW 40 rotor, Beckman) at 4uC for 4 h. The PRRSV particles band were harvested and pelleted at 120,0006g at 4uC for 2 h to remove the traces of sucrose. Then the PRRSV pellet was resuspended in phosphate buffered saline (PBS), quantitated by optical density (OD) measurement as described previously [6] and used for indirect ELISA (iELISA), T lymphocyte proliferation and cytokine assays. HEK-293A cells (ATCC CRL1573) were used for transfection of plasmids. All cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM Lglutamine, 100 U penicillin/ml and 100 mg streptomycin/ml.
RT-PCR for amplification of entire gene encoding for porcine IL-2
Based on porcine IL-2 gene sequence (GenBank accession no. NM_213861), one pair of PCR primers was designed as following: IL-2-Fwd: 59-GATGAATTCCACCATGGATAAGATGCAGC-39 (containing EcoRI site italicized); IL-2-Rev: 59-GCGCTCGAGT-TAAGTCAGTGTTGAGTAGATGCTT-39 (containing XhoI site italicized). Porcine spleen cells from 8-week-old Yorkshire swine were isolated by mechanical disruption and filtration through a 75 mm cell filter followed by hypotonic lysis of erythrocytes, then stimulated with ConA (10 mg/ml; Sigma-Aldrich, St. Louis, MO, USA) for 24 h in vitro. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) as the manufacturer's protocol. The cDNA was synthesized using oligo d(T) [12] [13] [14] [15] [16] [17] [18] primer. Then the entire gene encoding for porcine IL-2 (487 bp) was amplified from the cDNA. The amplification was performed in a 50 ml reaction mixture containing 1.5 mM MgCl 2 , 16PCR buffer, 0.2 mM of each dNTP, 20 pmol of each primer, 1.5 U of TaqDNA polymerase (Invitrogen, Carlsbad, CA, USA) and 2 ml of the cDNA. The reaction was run in a thermocycler (DNA Engine, PTC-0200; Bio-Rad Laboratories, Hercules, CA, USA) with the following program: denaturation at 94uC for 5 min, 30 cycles composed of denaturation at 94uC for 40 s, annealing at 60uC for 40 s and extension at 72uC for 1 min, and was ended with a final extension step of 10 min at 72uC.
Modification of the pVAX1
ß vector site italicized). Then the GP3-GP5 gene was cloned into pMVAX1 ß vector using EcoRI and XhoI sites (Fig. 1B) . All the expression plasmids were sequenced to confirm the correct tandem in frame insertion of individual gene. 
Western blotting assay
Western blotting was carried out as described previously [10] . Briefly, the cell lysates were resolved in a 10% polyacrylamide gel. The separated proteins were then transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA) and probed with PRRSV-specific antiserum of pigs or mouse monoclonal antibody against swine IL-2 (Invitrogen, Camarillo, CA, USA), respectively. Specific reaction products were detected with horseradish peroxidase-conjugated Staphylococcal Protein A (SPA-HRP, Boshide, Wuhan, China) or HRP-conjugated goat anti-mouse IgG (Boshide, Wuhan, China). The membranes were developed using Supersignal West Pico Chemiluminescent Substrate according to the manufacturer's suggestions (Pierce, Rockford, IL, USA). Digital signal acquisition and analysis were conducted by the Quantity One program, version 4.6 (Bio-Rad).
Bioactivity of IL-2 expressed by pVAX1
ß -IL-2 and pMVAX1
Cells transfected with individual plasmid were frozen and thawed three times and then centrifuged at 13,000 rpm for 10 min in a microcentrifuge (Eppendorf 5415R). Supernatants were harvested and the bioactivity of IL-2 was examined as described before [28] , with a little modification. Briefly, porcine spleen from 8-week-old Yorkshire swine was collected aseptically in PBS. Part of the spleen (about 50 g) was cut, minced with scissors and then passed through a 75 mm cell filter to obtain a homogeneous cell suspension. The spleen cells were collected after centrifugation at 2506g for 10 min at 4uC and resuspended in Hank's balanced salt solution (HBSS). Cell suspension was then overlaid on equal volume of Histopaque-1077 (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged at 1,0006g. Cells were washed twice in serum-free RPMI-1640 and planted in six well cell culture plates in RPMI-1640 medium containing 10% FBS at a concentration of 1610 7 cells/ml. The cells were stimulated with ConA (10 mg/ ml; Sigma-Aldrich) for 24 h and the residual ConA in the cell supernatant was removed by incubating with 0.1 M a-methyl Dmannoside for 30 min. The endogenous IL-2 protein in the supernatant was purified according to the previous report [28] . The stimulated cells were applied to Histopaque-1077 (SigmaAldrich), and live cells were selected after centrifugation. The enriched viable cells were resuspended in RPMI-1640 medium containing 10% FBS and cultured at 5610 6 cells/ml with twofolds dilutions of the supernatants from cells transfected with individual plasmid in triplicates in 96-well plates (100 ml per well). RPMI-1640-FBS only was used as negative control. The purified endogenous IL-2 protein was used as positive control. After incubation at 37uC for 48 h, 20 ml MTT (3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide, 5 mg/ml) was added to each well and reacted for 4.5 h. Then 100 ml of lysis buffer (20% SDS/50% DMF) was added. Plates were incubated for 20 h at 37uC and the OD values were measured at 570 nm. OD IL-2 / OD negative $1.5 was defined as the positive criteria for the biological activity of IL-2.
Preparation of DNA plasmids
All plasmids for DNA immunizations were grown in E.coli DH5a strain (Invitrogen, Carlsbad, CA, USA), and large-scale preparation of the plasmid DNA was carried out using Qiagen EndoFree Plasmid-Giga kits (Qiagen, Chatsworth, CA, USA) according to the manufacturer's instructions.
Animal experiments
The ARRIVE Guidelines Checklist-NC3Rs for Animal Research was provided in Table S1 .
Immunization of mice. A total of 75, 6-week-old female BALB/c mice (provided by the Animal Center of Nanjing Army Hospital, Nanjing, China) were randomly divided into 5 groups each with 15. Groups 1-4 were individually inoculated with 100 mg of pVAX1
ß -GP35 and pMVAX1 ß -GP35 in 0.2 ml PBS. Group 5 was inoculated with 0.2 ml PBS. All groups of mice were injected intradermally twice at 3-week intervals using regular syringes and needles. At 21, 35 and 49 days post primary immunization (dpi), five mice from each group were euthanized and the sera were harvested for the detection of antibodies against PRRSV using iELISA and serum neutralization (SN) assays. The lymphocytes were separated from the spleen of each mouse at 35 and 49 dpi for the detection of PRRSV-specific cell mediate immune responses.
Vaccination of pigs. Forty-five 21-day-old crossbreed (Landrace6local stock) pigs were obtained from a local farm without PRRSV, porcine circovirus 2 (PCV-2), porcine parvovirus (PPV), pseudorabies virus (PRV) and Actinobacillus pleuropneumoniae (APP) history. All pigs were tested and proven to be seronegative for PRRS by iELISA and PRRSV negative by RT-PCR. The animals were then randomly divided into 9 groups, numbered, and housed in separate rooms. Group 1 was injected with 1 ml PBS. Groups 2-6 were individually injected with 500 mg of pVAX1 Health Products Co., Ltd, China). The plasmid DNA, attenuated PRRS vaccine or PBS was injected in the cervical region muscles using regular syringes and needles and the immunization was boosted 28 days later. The sera were collected from each pig at 28, 42 and 56 dpi to detect antibodies to PRRSV using iELISA and SN assays. At 42 and 56 dpi, the heparinized blood was used to isolate peripheral blood mononuclear cells (PBMCs) for T lymphocyte proliferation assay. At 42 dpi, PBMCs were isolated from the blood of pigs and stimulated with purified SD-JN PRRSV antigen (10 mg/ml). The supernatant was obtained to detect the levels of Th1-type cytokine IFN-c and Th2-type cytokine IL-4. PBMCs isolated from pigs at 42 dpi were also used for Cytotoxic T-lymphocyte (CTL) assay. At 56 dpi, all pigs were challenged intramuscularly with 1610 5 TCID 50 PRRSV SD-JN strain (F6 passage, 1 ml) using regular syringes and needles. And then the animals were monitored daily for rectal temperatures and clinical signs until 21 days post challenge (dpc).
iELISA. The purified SD-JN PRRSV antigen was used as iELISA antigen and coated in 96-well plates at the concentration of 1.0 mg/ml. The plates were blocked with 0.15% BSA in PBS. The sera of mice or pigs were diluted 1:2 serially in PBS-T (PBS containing 0.5% Tween80, PBS-T) and added into the plates. 3 wells were repeated per dilution. After incubation for 60 min at 37uC, the wells were washed with PBS-T for three times and incubated with Goat anti-mouse IgG-HRP or SPA-HRP (Boshide, Wuhan, China) for 60 min at 37uC. The plates were incubated with substrate solution O-phenilendiamine (OPD) at 37uC for 15 min and the reaction was stopped by adding 2 M H 2 SO 4 solution in each well. The OD values were read at 490 nm in an ELISA reader. Meanwhile, the PRRSV negative sera of mice or pigs were used as negative controls. The results were expressed as the ratio of OD 490 nm produced by the serum samples compared to negative control serum. Sera, giving a ratio value higher than 2.1, were considered to be positive sera. The titers were expressed as the highest dilution of antibody producing 2.1 ratio value [6, 10] .
SN assays. SN assays were performed as previously described [6] . All serum samples from mice and pigs were heat inactivated (56uC, 30 min) and 1:2 serially diluted. Then, the serial dilutions of serum were mixed with equal volumes of 200 TCID 50 SD-JN PRRSV. After incubation at 37uC for 1 h, the mixtures were transferred to MARC-145 monolayers in 96-well tissue culture plates. Then, the plates were incubated and observed daily for up to 5 days for the appearance of CPE. Meanwhile, the PRRSV positive and negative sera of pigs were used as positive and negative controls, respectively. CPE was used to determine the end-point titers that were calculated as the reciprocal of the last serum dilution to neutralize 100 TCID 50 of PRRSV in 50% of the wells.
T lymphocyte proliferation assay. Lymphocytes were isolated individually from the spleen of each mouse or heparinized blood of pigs with lymphocyte separation medium (Boshide, Wuhan, China), suspended to 5610 6 /ml with RPMI complete medium (RPMI-1640 containing 10% FBS, 2 mM L-glutamine, 50 mM b-mercaptoethanol, 200 U/ml penicillin, 200 mg/ml streptomycin, 100 U/ml of mycostatin) and seeded in 96-well flat-bottom plates at 100 ml per well. Each cell sample was plated in triplicate. The culture was stimulated with purified SD-JN PRRSV antigen at a final concentration of 10 mg/ml or unstimulated, respectively. Meanwhile, phytohemagglutinin (PHA) (10 mg/ml; Sigma-Aldrich) was used as a positive control. After incubation for 45 h at 37uC with 5% CO 2 , the proliferation responses were detected by a standard MTT method. T lymphocyte proliferation was expressed as stimulation index (SI), which is the ratio of OD 570 nm of stimulated well to that of unstimulated one [6, 10] .
Cytokine assays. Subsets of Th cells can be distinguished by their pattern of cytokine expression. Th1 cells produce IFN-c, IL-2, and lymphotoxin, and Th2 cells produce IL-4, IL-5, IL-10 and IL-13. To distinguish the subsets, PBMCs (5610 6 /ml, 100 ml per well) isolated from the blood of pigs were stimulated with purified SD-JN PRRSV antigen at the final concentration of 10 mg/ml. After 72 h, the cells were centrifuged and the supernatant was collected to examine the levels of the Th1-type cytokine IFN-c and Th2-type cytokine IL-4 using commercially available porcine IFNc/IL-4 ELISA kits (Biosource, Camarillo, CA, USA) following the manufacturer's instructions.
CTL assay. CTL assay was carried out as described previously [29] , with a little modification. Briefly, 21-day-old pig free of PRRSV, tested to be seronegative for PRRS by iELISA and SN assays, was used for collecting PAMs by lung lavage. PAMs were incubated with PRRSV SD-JN at an MOI of 0.01 for 24 h and used as the target cells. PBMCs isolated from pigs at 42 dpi were used as effector cells. 1610 7 /ml and 5610 6 /ml of effector cells were suspended in phenol red-free RPMI-1640 medium containing 2% BSA, 2 mM glutamine, and 1% penicillin and streptomycin, and seeded in 96-well round-bottom plates with 100 ml per well. Each cell sample was plated in triplicate. Subsequently 100 ml of the target cells (1610 4 /well) was added in each well and incubated for 4-6 h at 37uC with 5% CO 2 . The supernatant was harvested, and the substrate tetrazolium salt was added. The OD values were read at 490 nm in an ELISA reader. The specific lactate dehydrogenase (LDH) activity release was calculated by using following formula: (experimental release-spontaneous release)/(maximum releasespontaneous release) 6100.
Clinical evaluations and gross lesions. The severity of the clinical signs was evaluated daily after challenge as reported [8, 10] . Observations included behavior, respiration and cough. Scores for each of three individual observations ranged from 1 to 4. The overall score for clinical condition was determined by sum of daily observations of behavior, respiration and cough. For example, a clinically normal animal would be given a total score of 3 (i.e., behavior = 1, respiration = 1, cough = 1), an animal with maximum clinical illness would be given a total score of 9 (i.e., behavior = 3, respiration = 3, cough = 3) and a dead animal would be given a total score of 12 (i.e., behavior = 4, respiration = 4, cough = 4). Sequential blood samples were collected from all animals at 0, 7, 14 and 21 dpc for isolation of PRRSV. The experiments were terminated on 21 dpc and all the animals were humanely euthanized. The gross lesions of lungs were evaluated at necropsy. Lungs were evaluated by the percentage of lesions noted per lobe, and then, using a standard scoring system, an overall level of gross lung pathology was determined [30] . The histological pathology of lungs was determined as described [31] .
Viremia assessment. Viremia in challenged pigs was determined as previously described [32] . MARC-145 cells were seeded in 12-well plates and grown to 70-80% confluence. Cells were inoculated with respective serum samples for 1 h and DMEM supplemented with 2% FBS, 2 mM L-glutamine, 100 U penicillin/ml and 100 mg streptomycin/ml was added. CPE in each MARC-145 cell culture well was observed microscopically for 5 days and the percentage of wells positive for CPE was calculated per group.
Statistical analysis
Data were compared and the differences were determined by One-way repeated measurement ANOVA and Least significance difference (LSD). A P-value ,0.05 was considered statistically significant [8] . Figure 5 . PRRSV-specific antibody responses in pigs immunized with PBS, individual plasmid or attenuated PRRS vaccine. (A) iELISA analysis of sera from pigs immunized with PBS, individual plasmid or attenuated PRRS vaccine in the cervical region muscles using regular syringes and needles. Serum samples (n = 5) were collected at various time-points and antibodies to purified SD-JN PRRSV antigen were detected using iELISA. Data were shown as mean 6standard error. (B) Neutralizing antibody responses in pigs immunized with PBS, individual plasmid or attenuated PRRS vaccine in the cervical region muscles using regular syringes and needles. Serum samples (n = 5) were collected at various time-points and detected by SN assays. The titers of neutralizing antibodies were expressed as the reciprocal of the last serum dilution to neutralize 100 TCID 50 of PRRSV in 50% of the wells [6, 10] . Data were shown as mean6standard error. doi:10.1371/journal.pone.0090326.g005 Figure 6 . Lymphocyte proliferative responses in pigs immunized with PBS, individual plasmid or attenuated PRRS vaccine in the cervical region muscles using regular syringes and needles. Heparinized blood samples (n = 5) were collected at days 42 and 56 dpi and PBMCs were stimulated with purified SD-JN PRRSV antigen (10 mg/ml) in triplicate. After 45 h of stimulation, MTT was added and the proliferation responses were detected by a standard MTT method [6, 10] . The PHA control sample showed a stimulation index of 6-8. Data were shown as mean6standard error. doi:10.1371/journal.pone.0090326.g006 Figure 7 . The concentrations (pg/ml) of Th1-type cytokine IFNc and Th2-type cytokine IL-4 in the supernatants. PBMCs (5610 6 /ml, 100 ml per well) were isolated from the blood of pigs at 42 dpi and stimulated with purified SD-JN PRRSV antigen (10 mg/ml). After 72 h, the supernatant fluids were collected to examine the levels of the Th1-type cytokine IFN-c and Th2-type cytokine IL-4 using commercially available pig cytokine ELISA kits. Data were shown as mean6standard error. doi:10.1371/journal.pone.0090326.g007 GM-CSF [9] and IFNa/IFNc [10] . However, these PRRS genetic engineering vaccines cannot induce sufficient protective immunity against PRRSV challenge. In this study, porcine IL-2 and GP3-GP5 of PRRSV were expressed by the gene regulatory plasmid pMVAX1 It was reported that insertion of the rabbit b-Globin Intron II gene sequence upstream of the F coding region of RSV could circumvent the tendency of RSV F RNA to undergo aberrant splicing and increase the protein expression in vitro [22] . Here a modification of pVAX1 ß vector by including the rabbit b-Globin Intron II gene sequence under the control of a CMV promoter results in higher levels of GP35 or IL-2 expression in vitro. The tendency of GP35 or IL-2 RNA to undergo aberrant splicing might be circumvented. As a result, the expression level and immunogenicity of GP35 or IL-2 were improved.
It was reported that GP3 of PRRSV can induce neutralizing antibody and plays an important role in clearing the virus infection [34] . GP5 can induce higher titers of neutralizing antibody, and three B-cell epitopes in GP5 have been identified using monoclonal antibodies [35, 36] . The results of SN assays showed that pMVAX1 ß -GP35 could induce higher neutralizing antibodies than pVAX1 ß -GP35 in mice (Fig. 3B) . In addition, PRRSVspecific T lymphocyte proliferation responses from the group of pMVAX1 ß -GP35 were significantly higher than the group that received pVAX1 ß -GP35 in mice (Fig. 4) . So pMVAX1 ß -GP35 was selected as PRRS DNA vaccine candidate and further studied in pigs. pVAX1 ß -GP35 cannot provide efficient protection in pigs in our previous report [10] and was not investigated any further. PRRSV-specific humoral immune response, cell mediated immune response and protection provided by pMVAX1 ß -GP35 might be better than pVAX1 ß -GP35 in pigs, but it needs further studies and comparisons in the future.
It was found that pigs vaccinated with pMVAX1 (Fig. 9, Table 1 ), which was coincident with the viraemia Table 2 . Development of viremia in vaccinated animals. and histological examination (Fig. 10 , Table 2 ). The enhanced PRRSV-specific humoral and cell mediated immunity induced by pMVAX1 ß -IL-2+pMVAX1 ß -GP35 could provide complete protection against homogenous challenge.
In summary, pMVAX1 ß -IL-2+pMVAX1 ß -GP35 could provide similar protective efficiency with attenuated PRRS vaccine. To our knowledge, this study was the first demonstration that porcine IL-2 and GP3-GP5 of PRRSV were expressed under the control of rabbit b-globin intron II gene and pMVAX1 
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